Posted in | News | Graphene

China's Graphene Market Could Achieve 95% CAGR from 2014 to 2020

Research and Markets has announced the addition of the "Global & Chinese Graphene Industry - 2015" report to their offering.

Currently graphene is still in the research stage. The limitations of preparative technique and the inactive downstream demand determined that the graphene has yet to achieve large-scale mass production.

In 2014, electronics, optoelectronics and data storage accounts for nearly 31% of global gaphene demand, composites ranks behind with a share of nearly 24%.

Most graphene producers currently produce graphene nanoplatelets and graphene oxide. Within the last year graphene producers have increased production capabilities considerably. XG Sciences, Angstron Materials and Vorbeck have increased, or are planning to increase, their production capacities twenty-fold.

Producers of graphene are generally small, start-up companies who have witnessed an explosion in demand for their materials from a variety of industries. Companies such as IBM and Samsung are pursuing applications for graphene in electronics and optics, which are likely only to be realized in the medium to long-term. Most near-term demand is for composites and coatings for application in the automotive, plastics, coatings, construction, metals, batteries, aerospace and energy markets.

The market size of China's graphene market is about 29 million RMB, and could achieve a CAGR of 95% from 2014 to 2020. The driving forces mainly comes from composites and touch screen market.

In 2014, graphene composites markets in China achieves 4.77 million RMB sales, accounting for 16.4% of total graphene sales in China.

There are approximately 10 major graphene-related companies in China, some of them declared that they has accessed mass-production of graphene, but actually their products are graphene powder. This lead to a false prosperity in China's capital market in 2014.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.